Skip to content
Billionaire Profile
Zhao Tao
Global Rank
#2239

Image: Soboky | CC BY-SA 4.0 | via Wikimedia Commons

Zhao Tao

CEO, Pharmaceuticals
Xi'an, China
Real-Time Net Worth
$1.88B
Estimated based on Pharmaceuticals stock value as of September 10, 2026
-0.28% (24h)
Age
49
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
Singapore

Biography

Zhao Tao, born January 28, 1977, is a prominent figure in the pharmaceutical industry and is known for her role as the chairman of Shandong Buchang Pharmaceuticals, a supplier of traditional Chinese medicine. Her career in the industry has contributed significantly to her estimated net worth of $2.0 billion. Beyond her business acumen, Zhao is a celebrated Chinese actress, known for her collaboration with director Jia Zhangke. She holds a Master of Business Administration from Fordham University and holds a Singapore passport.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$1.88B
2025$2.00B
2024$2.00B

Portfolio Holdings

China Grand Pharmaceutical and Healthcare Holdings Limited

China Grand Pharmaceutical and Healthcare Holdings Limited

0512.HKhealthcare
Market Cap
$27.9B
Stock Price
$6.66
Wuhan, Hubei, China
12,440 employees

In-Depth Profile

Zhao Tao, born January twenty-eighth, nineteen seventy-seven, is a prominent figure in the pharmaceutical industry and is known for her role as the chairman of Shandong Buchang Pharmaceuticals, a supplier of traditional Chinese medicine. Her career in the industry has contributed significantly to her estimated net worth of two billion dollars. Beyond her business acumen, Zhao is a celebrated Chinese actress, known for her collaboration with director Jia Zhangke. She holds a Master of Business Administration from Fordham University and holds a Singapore passport.

Zhao Tao's substantial wealth is primarily derived from her leadership and significant ownership stake in Shandong Buchang Pharmaceuticals. This company operates within the healthcare industry, specifically focusing on the development, manufacturing, and distribution of traditional Chinese medicine. As chairman, Zhao Tao oversees the strategic direction and operations of this established pharmaceutical enterprise. The core business involves the production of various traditional Chinese medicine formulations, which are utilized for a range of health conditions. The success of these products in the market directly contributes to the company's profitability and, consequently, to the valuation of Zhao Tao's holdings. Her role as chairman places her at the helm of a key player in a specialized segment of the global healthcare sector.

Zhao Tao's career progression within the pharmaceutical industry culminated in her assuming the leadership of Shandong Buchang Pharmaceuticals. This significant milestone occurred in the year two thousand sixteen, when she took on the role of chairman. This appointment marked a pivotal moment in her professional journey, placing her in a position of considerable influence within the company and the broader traditional Chinese medicine sector. Her leadership involves guiding the company's expansion, managing its product portfolio, and navigating the complexities of the pharmaceutical market. The value of her ownership stake is directly tied to the performance and growth of the company under her direction.

The foundation of Zhao Tao's business acumen, which underpins her success in the pharmaceutical industry, was further strengthened by her academic pursuits. She earned a Master of Business Administration from Fordham University, providing her with a comprehensive understanding of business strategy, finance, and management principles. This advanced education likely equipped her with the analytical and leadership skills necessary to effectively steer a large pharmaceutical company. Her academic background, combined with her practical experience, has been instrumental in building and maintaining her substantial wealth through her involvement with Pharmaceuticals.

As a prominent figure in the healthcare industry, Zhao Tao's wealth is a reflection of the scale and success of Shandong Buchang Pharmaceuticals. The company's operations, centered on traditional Chinese medicine, cater to a significant market, contributing to robust revenue generation. Her ownership stake translates directly into a substantial portion of her estimated net worth. Through her leadership as chairman, she plays a direct role in the company's strategic decisions and overall performance, which in turn impacts the value of her assets. Her trajectory from an educational background in business to a leading position in the pharmaceutical sector illustrates a focused career progression that has yielded significant financial returns.

Career Milestones

2016

Chairman of Shandong Buchang Pharmaceuticals

Assumed leadership of Shandong Buchang Pharmaceuticals, a supplier of traditional Chinese medicine.

Controversies & Challenges

2019

College Admissions Scandal

Zhao Tao was involved in the college admissions scandal, where she reportedly paid $6.5 million to secure her daughter's admission to Stanford University.

Billionaires Connected to Zhao Tao

Peers in Healthcare

All Healthcare billionaires

Richest in Singapore

All billionaires from Singapore

Adjacent Global Ranks

Full global ranking

Frequently Asked Questions

What is Zhao Tao's net worth in 2026?
As of 2026, Zhao Tao's estimated net worth is $1.878 billion, ranking #2239 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Zhao Tao make their money?
Zhao Tao's wealth primarily comes from Pharmaceuticals, most notably through Pharmaceuticals.
Where is Zhao Tao from?
Zhao Tao is from Singapore.
How old is Zhao Tao?
Zhao Tao is 49 years old.

Sources & References

  1. Zhao Tao — Forbes profile Forbes